High-efficiency transduction of freshly isolated human tumor cells using adenoviral interleukin-2 vectors

Human Gene Therapy

Volumn 7, Issue 10, 1996, Pages 1233-1239

  Leimig, Thasia ^a   Brenner, Malcolm ^a   Ramsey, Jay ^b   Vanin, Elio ^a,c   Blaese, Michael ^b   Dilloo, Dagmar ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ADENOVIRUS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DELETION MUTANT; EXPRESSION VECTOR; GENETIC TRANSDUCTION; HISTOCOMPATIBILITY COMPLEX; HUMAN; HUMAN CELL; IMMUNOMODULATION; NEUROBLASTOMA CELL;

ADENOVIRIDAE; RODENTIA;

EID: 0030035265     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.10-1233     Document Type: Article

References (26)

1. AMIN, R., WILMOTT, R., SCHWARZ, Y., TRAPNELL, B., and STARK, J. (1995). Replication-deficient adenovirus induces expression of interleukin-8 by airway epithelial cells in vivo. Hum. Gene Ther. 6, 145-154.
2. BLAESE, M., BLANKENSTEIN, T., BRENNER, M., COHEN-HAGUENAUER, O., GANSBACHER, B., SORRENTINO, B., and VELU, R. (1995). European School of Oncology Position Paper Gene Therapy for the Medical Oncologist. Eur. J. Cancer 31A, 1531-1537.
3. BRENNER, M.K., FURMAN, W.L., SANTANA, V.M., BOWMAN, L., and MEYER, W. (1992). Phase I study of cytokine-gene modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma. Hum. Gene Ther. 3, 665-676.
4. BRODY, S.L., JAFFE, H.A., HAN, S.K., WERSTO, R.P., and CRYSTAL, R.G. (1994). Direct in vivo gene transfer and expression in malignant cells using adenovirus vectors. Hum. Gene Ther. 5, 437-447.
5. COZE, C., AALTO-SETALA, K., BRENNER, M., CHIANG, Y., GANGAVALLI, R., and LEIMIG, T. (1995). Characteristics and immunomodulatory properties of human neuroblastoma cells after retrovirus-mediated gene transfer of the cytokine genes IL-2 and IFN-gamma. Transgenics 1, 585-595.
6. CRYSTAL, R.G., MCELVANEY, N.G., ROSENFELD, M.A., CHU, C.-S., MASTRANGELI, A., HAY, J.G., BRODY, S.L., JAFFE, H.A., EISSA, N.T., and DANEL, C. (1994). Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genet. 8, 42-51.
7. FAVROT, M.C., COMBARET, V., GOILLOT, E., TABONE, E., BOUFFET, E., DOLBEAU, D., BOUVIER, R., COZE, C., MICHON, J., and PHILIP, T. (1991). Expression of leucocyte adhesion molecules on 66 clinical neuroblastoma specimens. Int. J. Cancer 44, 502-510.
8. GANSBACHER, B., ZIER, K., DANIELS, B., CRONIN, K., BANNERJI, R., and GILBOA, E. (1990). Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J. Exp. Med. 172, 1217-1224.
9. GANSBACHER, B., HOUGHTON, A., LIVINGSTON, P., MINASIAN, L., ROSENTHAL, F., GILBOA, E., GOLDE, D., OETTGEN, H., STEFFENS, T., YANG, S.Y., and WONG, G. (1992). A pilot study of immunization with HLA-A2 matched allogeneic melanoma cells that secrete Interleukin-2 in patients with metastatic melanoma. Hum. Gene Ther. 3, 677-690.
10. HADDADA, H., RAGOT, T., CORDIER, L., DUFFOUR, M.T., and PERRICAUDET, M. (1993). Adenoviral interleukin-2 gene transfer into P815 tumor cells abrogates tumorigenicity and induces antitumoral immunity in mice. Hum. Gene Ther. 4, 703-711.
11. HUANG, S., ENDO, R.I., and NEMEROW, G.R. (1995). Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery. J. Virology 69, 2257-2263.
12. LEIMIG, T., FOREMAN, N., RILL, D., COZE, C., HOLLADAY, M., and BRENNER, M. (1994). Immunomodulatory effects of human neuroblastoma cells transduced with a retroviral vector encoding interleukin-2. Cancer Gene Ther. 1, 253-258.
13. NABEL, G.J., NABEL, E.G., YANG, Z.Y., FOX, B.A., PLAUTZ, G.E., GAO, X., HUANG, L., SHU, S., GORDON, D., and CHANG, A.E. (1993). Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc. Natl. Acad. Sci. USA 90, 11307-11311.
14. O'MALLEY, B.W., JR., CHEN, S-H., SCHWARTZ, M.R., and WOO, S.L.C. (1995). Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res. 55, 1080-1085.
15. RECOMBINANT DNA ADVISORY COMMITTEE. (1995). Attachment IV Recombinant DNA Advisory Committee (RAC) Data Management Report - December 1994. Hum. Gene Ther. 6, 1111.
16. RILL, D.R., BUSCHLE, M., FOREMAN, N.K., BARTHOLOMEW, C., MOEN, R.C., SANTANA, V.M., IHLE, J.N., and BRENNER, M.K. (1992). Retrovirus mediated gene transfer as an approach to analyze neuroblastoma relapse after autologous bone marrow transplantation. Hum. Gene Ther. 3, 129-136.
17. SANES, J.R., RUBENSTEIN, J.L.R., and NICOLAS, J. (1986). Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J. 5, 3133-3142.
18. SIMON, R.H., ENGELHARDT, J.F., YANG, Y., ZEPEDA, M., PENDLETON, S.W., GROSSMAN, M., and WILSON, J.M. (1993). Adenovirus-mediated transfer of the CFTR gene to lung of non-human primates. Hum. Gene Ther. 4, 771-780.
19. SMITH, C.A., NG, C.Y.C., HESLOP, H.E., HOLLADAY, M.S., RICHARDSON, S., TURNER, E.V., LOFTIN, S.K., LI, C., BRENNER, M.K., and ROONEY, C.M. (1995). Production of genetically modified EBV-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease. J. Hematother. 4, 73-79.
20. SMITH, T.A., MEHAFFEY, M.G., KAYDA, D.B., SAUNDERS, J.M., YEI, S., TRAPNELL, B.C., MCCLELLAND, A., and KALEKO, M. (1993). Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nature Genet. 5, 397-402.
21. TANG, D., JOHNSTON, S.A., and CARBONE, D.P. (1994). Butyrate-inducible and tumor-restricted gene expression by adenovirus vectors. Cancer Gene Ther. 1, 15-20.
22. TEPPER, R.I., and MULÉ, J.J. (1994). Experimental and clinical studies of cytokine gene-modified tumor cells. Hum. Gene Ther. 5, 153-164.
23. YANG, Y., NUNES, F.A., BERENCSI, K., FURTH, E.E., and WILSON, J.M. (1994). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411.
24. YEI, S., MITTEREDER, N., WERT, S., WHITSETT, J.A., WILMOTT, R.W., and TRAPNELL, B.C. (1994). In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung. Hum. Gene Ther. 5, 731-744.
25. ZABNER, J., COUTURE, L.A., GREGORY, R.J., GRAHAM, S.M., SMITH, A.E., and WELSH, M.J. (1993). Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75, 207-216.
26. ZSENGELLER, Z.K., WERT, S.E., HULL, W.M., HU, X., YEI, S., TRAPNELL, B.C., and WHITSETT, J.A. (1994). Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. Hum. Gene Ther. 6, 459-469.